| Deciphering the state of immune silence in fatal COVID-19 patients P Bost, F De Sanctis, S Canè, S Ugel, K Donadello, M Castellucci, D Eyal, ... Nature communications 12 (1), 1428, 2021 | 131 | 2021 |
| Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection M Codagnone, E Cianci, A Lamolinara, VC Mari, A Nespoli, E Isopi, ... Mucosal immunology 11 (1), 35-49, 2018 | 102 | 2018 |
| Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab L Castagnoli, M Iezzi, GC Ghedini, V Ciravolo, G Marzano, A Lamolinara, ... Cancer research 74 (21), 6248-6259, 2014 | 95 | 2014 |
| Multiorgan metastasis of human HER-2+ breast cancer in Rag2−/−; Il2rg−/− mice and treatment with PI3K inhibitor P Nanni, G Nicoletti, A Palladini, S Croci, A Murgo, ML Ianzano, V Grosso, ... PloS one 7 (6), e39626, 2012 | 93 | 2012 |
| Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer G Corda, G Sala, R Lattanzio, M Iezzi, M Sallese, G Fragassi, ... The Journal of pathology 241 (3), 350-361, 2017 | 83 | 2017 |
| Resolvin D1 reduces lung infection and inflammation activating resolution in cystic fibrosis E Isopi, D Mattoscio, M Codagnone, VC Mari, A Lamolinara, S Patruno, ... Frontiers in immunology 11, 581, 2020 | 71 | 2020 |
| Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 A Matte, A Recchiuti, E Federti, B Koehl, T Mintz, W El Nemer, PL Tharaux, ... Blood, The Journal of the American Society of Hematology 133 (3), 252-265, 2019 | 67 | 2019 |
| Induction of immunosuppressive functions and NF-κB by FLIP in monocytes A Fiore, S Ugel, F De Sanctis, S Sandri, G Fracasso, R Trovato, S Sartoris, ... Nature Communications 9 (1), 5193, 2018 | 57 | 2018 |
| Disabled homolog 2 controls prometastatic activity of tumor-associated macrophages I Marigo, R Trovato, F Hofer, V Ingangi, G Desantis, K Leone, F De Sanctis, ... Cancer discovery 10 (11), 1758-1773, 2020 | 51 | 2020 |
| Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer L Castagnoli, GC Ghedini, A Koschorke, T Triulzi, M Dugo, P Gasparini, ... Oncogene 36 (12), 1721-1732, 2017 | 51 | 2017 |
| Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages A Recchiuti, S Patruno, D Mattoscio, E Isopi, A Pomilio, A Lamolinara, ... The FASEB journal 35 (4), 2021 | 48 | 2021 |
| Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema R Mastropasqua, R D’Aloisio, M Di Nicola, G Di Martino, A Lamolinara, ... Scientific reports 8 (1), 16548, 2018 | 48 | 2018 |
| Disruption of IFN-I signaling promotes HER2/Neu tumor progression and breast cancer stem cells L Castiello, P Sestili, G Schiavoni, R Dattilo, DM Monque, F Ciaffoni, ... Cancer Immunology Research 6 (6), 658-670, 2018 | 48 | 2018 |
| Pyrvinium pamoate induces death of triple-negative breast cancer stem–like cells and reduces metastases through effects on lipid anabolism R Dattilo, C Mottini, E Camera, A Lamolinara, N Auslander, G Doglioni, ... Cancer research 80 (19), 4087-4102, 2020 | 44 | 2020 |
| Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes D Mattoscio, E Isopi, A Lamolinara, S Patruno, A Medda, F De Cecco, ... Journal of Experimental & Clinical Cancer Research 40, 1-16, 2021 | 41 | 2021 |
| Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates F Giansanti, E Capone, S Ponziani, E Piccolo, R Gentile, A Lamolinara, ... Journal of Controlled Release 294, 176-184, 2019 | 40 | 2019 |
| Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies S Sandri, S Bobisse, K Moxley, A Lamolinara, F De Sanctis, F Boschi, ... Cancer Research 76 (9), 2540-2551, 2016 | 37 | 2016 |
| HER-2/neu mediates oncogenic transformation via altered CREB expression and function A Steven, S Leisz, C Massa, M Iezzi, R Lattanzio, A Lamolinara, J Bukur, ... Molecular cancer research 11 (11), 1462-1477, 2013 | 37 | 2013 |
| EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma E Capone, A Lamolinara, D D'Agostino, C Rossi, V De Laurenzi, M Iezzi, ... Journal of Controlled Release 277, 48-56, 2018 | 35 | 2018 |
| Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer V Rolih, J Caldeira, E Bolli, A Salameh, L Conti, G Barutello, F Riccardo, ... Cancers 12 (6), 1492, 2020 | 32 | 2020 |
Manuela Iezzichieti在 unich.it 的电子邮件经过验证
